Tumor necrosis factor: receptors and inhibitors - PubMed (original) (raw)

Affiliations

• PMID: 1654969

Review

Tumor necrosis factor: receptors and inhibitors

H Loetscher et al. Cancer Cells. 1991 Jun.

Abstract

Tumor necrosis factor (TNF) is a highly potent pleiotropic response modifier in inflammatory and immunologic host defense reactions. It can also be toxic to cells and elicit toxic systemic reactions, as evinced by certain pathophysiologic conditions that are initiated or aggravated by an excess of TNF. The cellular mechanisms for transducing TNF signals are complex. There are two forms of TNF, alpha and beta, and two distinct TNF receptors. Many cells express both receptor types simultaneously, even though neither membrane receptor can distinguish between TNF-alpha and TNF-beta. The effects of TNF are inhibited by binding proteins that are truncated fragments of the extracellular domains of the TNF receptors. The mechanisms by which these components of the TNF signal transmission pathways interact to mediate the pleiotropic effects of TNF remain unclear.

PubMed Disclaimer

Similar articles

• Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation.
  Gehr G, Gentz R, Brockhaus M, Loetscher H, Lesslauer W. Gehr G, et al. J Immunol. 1992 Aug 1;149(3):911-7. J Immunol. 1992. PMID: 1321854
• Soluble and cell surface receptors for tumor necrosis factor.
  Wallach D, Engelmann H, Nophar Y, Aderka D, Kemper O, Hornik V, Holtmann H, Brakebusch C. Wallach D, et al. Agents Actions Suppl. 1991;35:51-7. Agents Actions Suppl. 1991. PMID: 1664189 Review.
• Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
  Warzocha K, Bienvenu J, Coiffier B, Salles G. Warzocha K, et al. Eur Cytokine Netw. 1995 Mar-Apr;6(2):83-96. Eur Cytokine Netw. 1995. PMID: 7578992 Review.
• [Therapeutic perspectives of cytokines in respiratory allergy conditions].
  Nicod LP. Nicod LP. Allerg Immunol (Paris). 1992 Jun;24(6):197-8. Allerg Immunol (Paris). 1992. PMID: 1323298 Review. French.

Cited by

• TNF superfamily control of tissue remodeling and fibrosis.
  Steele H, Cheng J, Willicut A, Dell G, Breckenridge J, Culberson E, Ghastine A, Tardif V, Herro R. Steele H, et al. Front Immunol. 2023 Jul 3;14:1219907. doi: 10.3389/fimmu.2023.1219907. eCollection 2023. Front Immunol. 2023. PMID: 37465675 Free PMC article. Review.
• BrainBase: a curated knowledgebase for brain diseases.
  Liu L, Zhang Y, Niu G, Li Q, Li Z, Zhu T, Feng C, Liu X, Zhang Y, Xu T, Chen R, Teng X, Zhang R, Zou D, Ma L, Zhang Z. Liu L, et al. Nucleic Acids Res. 2022 Jan 7;50(D1):D1131-D1138. doi: 10.1093/nar/gkab987. Nucleic Acids Res. 2022. PMID: 34718720 Free PMC article.
• Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer.
  Liu Z, Kemp TJ, Gao YT, Corbel A, McGee EE, Roa JC, Wang B, Araya JC, Shen MC, Rashid A, Hsing AW, Hildesheim A, Ferreccio C, Pfeiffer RM, Pinto LA, Koshiol J. Liu Z, et al. Sci Rep. 2018 Apr 4;8(1):5671. doi: 10.1038/s41598-018-23848-8. Sci Rep. 2018. PMID: 29618736 Free PMC article.
• Apoptosis through Death Receptors in Temporal Lobe Epilepsy-Associated Hippocampal Sclerosis.
  Teocchi MA, D'Souza-Li L. Teocchi MA, et al. Mediators Inflamm. 2016;2016:8290562. doi: 10.1155/2016/8290562. Epub 2016 Feb 23. Mediators Inflamm. 2016. PMID: 27006531 Free PMC article.
• Clinical hypothermia temperatures increase complement activation and cell destruction via the classical pathway.
  Shah TA, Mauriello CT, Hair PS, Sandhu A, Stolz MP, Bass WT, Krishna NK, Cunnion KM. Shah TA, et al. J Transl Med. 2014 Jun 24;12:181. doi: 10.1186/1479-5876-12-181. J Transl Med. 2014. PMID: 24962100 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations